Synergy Ablation System
Device Cardiovascular
PDI 10840143902109
General payments
$9,391,030
Research payments
$194,451
Through program year 2025, $9,391,030 in general payments and $194,451 in research payments were reported against Synergy Ablation System (Cardiovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,997,610 | 13,150 |
| 2025 | Research | $37,050 | 10 |
| 2024 | General | $1,454,639 | 8,906 |
| 2024 | Research | $20,882 | 10 |
| 2023 | General | $1,686,889 | 8,495 |
| 2023 | Research | $80,875 | 40 |
| 2022 | General | $2,461,125 | 8,128 |
| 2022 | Research | $55,644 | 15 |
| 2021 | General | $1,790,767 | 4,812 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 83 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
43,491 general · 75 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.